Literature DB >> 29371069

Growing evidence supports 4CMenB effectiveness.

Shamez N Ladhani1, Ray Borrow2, Nick J Andrews3.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29371069     DOI： 10.1016/S1473-3099(18)30051-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  1 in total

1.  Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.

Authors:  María Victoria Humbert; Myron Christodoulides
Journal:  Vaccine       Date:  2018-05-24       Impact factor: 3.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.